These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15168383)

  • 1. Defective regulation of iron transporters leading to iron excess in the polymorphonuclear leukocytes of patients on maintenance hemodialysis.
    Otaki Y; Nakanishi T; Hasuike Y; Moriguchi R; Nanami M; Hama Y; Izumi M; Takamitsu Y
    Am J Kidney Dis; 2004 Jun; 43(6):1030-9. PubMed ID: 15168383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of tumor necrosis factor-α downregulate antimicrobial iron transport protein, Nramp1, in chronic hemodialysis patients: a key factor for infection risk.
    Moriguchi R; Otaki Y; Hazeki S; Shimada T; Matsumoto A; Kakita N; Kaibe S; Kuragano T; Nonoguchi H; Masayoshi N; Hasuike Y; Nakanishi T
    Am J Nephrol; 2012; 35(4):372-8. PubMed ID: 22508410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between transferrin receptor-ferritin index and conventional measures of iron responsiveness in hemodialysis patients.
    Chen YC; Hung SC; Tarng DC
    Am J Kidney Dis; 2006 Jun; 47(6):1036-44. PubMed ID: 16731299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Free circulating active elastase contributes to chronic inflammation in patients on hemodialysis.
    Khatib-Massalha E; Michelis R; Trabelcy B; Gerchman Y; Kristal B; Ariel A; Sela S
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F203-F209. PubMed ID: 29046295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferroportin in monocytes of hemodialysis patients and its associations with hepcidin, inflammation, markers of iron status and resistance to erythropoietin.
    Eleftheriadis T; Pissas G; Remoundou M; Filippidis G; Antoniadi G; Oustampasidou N; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2014 Jan; 46(1):161-7. PubMed ID: 23860963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison between the soluble transferrin receptor, transferrin saturation and serum ferritin as markers of iron state in hemodialysis patients.
    Beerenhout C; Bekers O; Kooman JP; van der Sande FM; Leunissen KM
    Nephron; 2002 Sep; 92(1):32-5. PubMed ID: 12187081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha-induced iron sequestration and oxidative stress in human endothelial cells.
    Nanami M; Ookawara T; Otaki Y; Ito K; Moriguchi R; Miyagawa K; Hasuike Y; Izumi M; Eguchi H; Suzuki K; Nakanishi T
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2495-501. PubMed ID: 16224057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil beta(2)-microglobulin and lactoferrin content in renal failure patients.
    Deicher R; Exner M; Cohen G; Haag-Weber M; Hörl WH
    Am J Kidney Dis; 2000 Jun; 35(6):1117-26. PubMed ID: 10845826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of iron metabolism in the acute-phase response: interferon gamma and tumour necrosis factor alpha induce hypoferraemia, ferritin production and a decrease in circulating transferrin receptors in cancer patients.
    Feelders RA; Vreugdenhil G; Eggermont AM; Kuiper-Kramer PA; van Eijk HG; Swaak AJ
    Eur J Clin Invest; 1998 Jul; 28(7):520-7. PubMed ID: 9726030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.
    Dhindsa S; Ghanim H; Batra M; Kuhadiya ND; Abuaysheh S; Green K; Makdissi A; Chaudhuri A; Dandona P
    Clin Endocrinol (Oxf); 2016 Nov; 85(5):772-780. PubMed ID: 27292585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of iron transport proteins divalent metal transporter-1, Ferroportin-1, HFE and transferrin receptor-1 in human monocyte-derived dendritic cells.
    Brinkmann M; Teuffel R; Laham N; Ehrlich R; Decker P; Lemonnier FA; Pascolo S
    Cell Biochem Funct; 2007; 25(3):287-96. PubMed ID: 16927405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of iron treatment on immune effector function and cellular iron status of circulating monocytes in dialysis patients.
    Sonnweber T; Theurl I; Seifert M; Schroll A; Eder S; Mayer G; Weiss G
    Nephrol Dial Transplant; 2011 Mar; 26(3):977-87. PubMed ID: 20826742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients.
    Costa E; Pereira BJ; Rocha-Pereira P; Rocha S; Reis F; Castro E; Teixeira F; Miranda V; do Sameiro Faria M; Loureiro A; Quintanilha A; Belo L; Santos-Silva A
    Am J Nephrol; 2008; 28(4):677-83. PubMed ID: 18354252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients?
    Cohen-Mazor M; Sela S; Mazor R; Ilan N; Vlodavsky I; Rops AL; van der Vlag J; Cohen HI; Kristal B
    Am J Physiol Heart Circ Physiol; 2008 Feb; 294(2):H651-8. PubMed ID: 18032524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous ascorbic acid medication on serum levels of soluble transferrin receptor in hemodialysis patients.
    Tarng DC; Hung SC; Huang TP
    J Am Soc Nephrol; 2004 Sep; 15(9):2486-93. PubMed ID: 15339999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated iron metabolism in patients on hemodialysis.
    Nakanishi T; Hasuike Y; Otaki Y; Nanami M; Kuragano T
    Contrib Nephrol; 2015; 185():22-31. PubMed ID: 26023012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor expression on reticulocytes as a marker of iron status in dialyzed patients.
    Soininen K; Punnonen K; Matinlauri I; Karhapää P; Rehu M
    Clin Chem Lab Med; 2010 Sep; 48(9):1239-45. PubMed ID: 20604729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration at translational but not transcriptional level of transferrin receptor expression following manganese exposure at the blood-CSF barrier in vitro.
    Li GJ; Zhao Q; Zheng W
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):188-200. PubMed ID: 15893546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum copper and ferroportin in monocytes of hemodialysis patients are both decreased but unassociated.
    Eleftheriadis T; Pissas G; Antoniadi G; Filippidis G; Golfinopoulos S; Spanoulis A; Liakopoulos V; Stefanidis I
    Int Urol Nephrol; 2014 Sep; 46(9):1825-31. PubMed ID: 24806658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between erythropoietin and peripheral polymorphonuclear leukocytes in hemodialysis patients.
    Kristal B; Shurtz-Swirski R; Shasha SM; Manaster J; Shapiro G; Furmanov M; Hassan K; Weissman I; Sela S
    Nephron; 1999; 81(4):406-13. PubMed ID: 10095176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.